|
|
The Mayo Clinic, the leading US hospital, will test Nevisense in Pilot |
|
|
Today the subscription period in SciBase rights issue begins |
|
|
SciBase letter from the CEO |
|
|
SciBase publishes prospectus |
|
|
Bulletin from the extraordinary general meeting in SciBase Holding AB (publ) |
|
|
SciBase Announces Positive Findings in Case Study Monitoring Treatment Outcomes in Atopic Dermatitis Patient |
|
|
Notice to extraordinary general meeting in Scibase Holding AB (publ) |
|
|
SciBase announces collaboration for prediction of atopic dermatitis in infants |
|
|
Interim report January 1 - September 30, 2024 |
|
|
SciBase decides on a directed issue of approximately SEK 22.5 million and a rights issue of up to approximately SEK 59.3 million |
